Suchbegriffe: ANTIFUNGAL AGENTS, . Treffer: 30
Sprute, R; Nacov, JA; Neofytos, D; Oliverio, M; Prattes, J; Reinhold, I; Cornely, OA; Stemler, J
Antifungal prophylaxis and pre-emptive therapy: When and how?
Mol Aspects Med. 2023; 92:101190
Doi: 10.1016/j.mam.2023.101190
PubMed
FullText
FullText_MUG
Angulo, DA; Alexander, B; Rautemaa-Richardson, R; Alastruey-Izquierdo, A; Hoenigl, M; Ibrahim, AS; Ghannoum, MA; King, TR; Azie, NE; Walsh, TJ
Ibrexafungerp, a Novel Triterpenoid Antifungal in Development for the Treatment of Mold Infections.
J Fungi (Basel). 2022; 8(11):
Doi: 10.3390/jof8111121
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Driemeyer, C; Falci, DR; Hoenigl, M; Cornely, OA; Chakrabarti, A; Gangneux, JP; Segal, E; Jürna-Ellam, M; Matos, T; Meis, JF; Perfect, JR; Arsenijevic, VA; Mares, M; Serban, DE; Pasqualotto, AC
The current state of Clinical Mycology in Eastern and South-Eastern Europe.
Med Mycol. 2022; 60(4):
Doi: 10.1093/mmy/myac017
Web of Science
PubMed
FullText
FullText_MUG
Hoenigl, M; Lewis, R; van, de, Veerdonk, FL; Verweij, PE; Cornely, OA
Liposomal amphotericin B-the future.
J Antimicrob Chemother. 2022; 77(Supplement_2): ii21-ii34.
Doi: 10.1093/jac/dkac353
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoenigl, M; Sprute, R; Arastehfar, A; Perfect, JR; Lass-Flörl, C; Bellmann, R; Prattes, J; Thompson, GR; Wiederhold, NP; Al, Obaidi, MM; Willinger, B; Arendrup, MC; Koehler, P; Oliverio, M; Egger, M; Schwartz, IS; Cornely, OA; Pappas, PG; Krause, R
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action.
Expert Opin Investig Drugs. 2022; 31(8):795-812
Doi: 10.1080/13543784.2022.2086120
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Kriegl, L; Boyer, J; Egger, M; Hoenigl, M
Antifungal stewardship in solid organ transplantation.
Transpl Infect Dis. 2022; 24(5):e13855
Doi: 10.1111/tid.13855
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Noster, J; Koeppel, MB; Desnos-Olivier, M; Aigner, M; Bader, O; Dichtl, K; Göttig, S; Haas, A; Kurzai, O; Pranada, AB; Stelzer, Y; Walther, G; Hamprecht, A
Bloodstream Infections Caused by Magnusiomyces capitatus and Magnusiomyces clavatus: Epidemiological, Clinical, and Microbiological Features of Two Emerging Yeast Species.
Antimicrob Agents Chemother. 2022; 66(2):e0183421
Doi: 10.1128/AAC.01834-21
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ocansey, BK; Dadzie, EA; Eduful, SK; Agyei, M; Osei, MM; Puplampu, P; Asamoah, I; Oladele, RO; Osaigbovo, II; Afriyie-Mensah, JS; Opintan, JA; Essien-Baidoo, S; Chakrabarti, A; Hoenigl, M; Denning, DW; Richardson, MD
Improving awareness, diagnosis and management of invasive fungal infections in Ghana: establishment of the Ghana Medical Mycology Society.
Med Mycol. 2022; 60(9):
Doi: 10.1093/mmy/myac069
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Chen, SC; Halliday, CL; Hoenigl, M; Cornely, OA; Meyer, W
Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease.
J Fungi (Basel). 2021; 7(1):
Doi: 10.3390/jof7010023
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Enko, D; Zelzer, S; Herrmann, M; Krause, R; Meinitzer, A
Implementation of a Dual-Column Liquid Chromatography-Tandem Mass-Spectrometry Method for the Quantification of Isavuconazole in Clinical Practice
J LAB PHYS. 2021;
Doi: 10.1055/s-0041-1730755
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoenigl, M; Sprute, R; Egger, M; Arastehfar, A; Cornely, OA; Krause, R; Lass-Flörl, C; Prattes, J; Spec, A; Thompson, GR; Wiederhold, N; Jenks, JD
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.
Drugs. 2021; 81(15):1703-1729
Doi: 10.1007/s40265-021-01611-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nucci, M; Jenks, J; Thompson, GR; Hoenigl, M; Dos Santos, MC; Forghieri, F; Rico, JC; Bonuomo, V; López-Soria, L; Lass-Flörl, C; Candoni, A; Garcia-Vidal, C; Cattaneo, C; Buil, J; Rabagliati, R; Roiz, MP; Gudiol, C; Fracchiolla, N; Campos-Herrero, MI; Delia, M; Farina, F; Fortun, J; Nadali, G; Sastre, E; Colombo, AL; Pérez Nadales, E; Alastruey-Izquierdo, A; Pagano, L
Do high MICs predict the outcome in invasive fusariosis?
J Antimicrob Chemother. 2021; 76(4):1063-1069
Doi: 10.1093/jac/dkaa516
Web of Science
PubMed
FullText
FullText_MUG
Palackic, A; Popp, D; Tapking, C; Houschyar, KS; Branski, LK
Fungal Infections in Burn Patients.
Surg Infect (Larchmt). 2021; 22(1):83-87
Doi: 10.1089/sur.2020.299
Web of Science
PubMed
FullText
FullText_MUG
Arastehfar, A; Gabaldón, T; Garcia-Rubio, R; Jenks, JD; Hoenigl, M; Salzer, HJF; Ilkit, M; Lass-Flörl, C; Perlin, DS
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium.
Antibiotics (Basel). 2020; 9(12):
Doi: 10.3390/antibiotics9120877
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Cornely, OA; Chen, SC; Thompson, GR; Hoenigl, M
Breakthrough invasive fungal infections: Who is at risk?
MYCOSES. 2020; 63(10): 1021-1032.
Doi: 10.1111/myc.13148
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Seidel, D; Cornely, OA; Chen, S; van Hal, S; Kauffman, C; Miceli, MH; Heinemann, M; Christner, M; Jover Sáenz, A; Burchardt, A; Kemmerling, B; Herbrecht, R; Steinmann, J; Shoham, S; Gräber, S; Pagano, L; Deeren, D; Slavin, MA; Hoenigl, M
Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry.
MYCOSES. 2020; 63(5): 437-442.
Doi: 10.1111/myc.13067
Web of Science
PubMed
FullText
FullText_MUG
Oladele, RO; Akase, IE; Fahal, AH; Govender, NP; Hoenigl, M; Gangneux, JP; Chiller, TM; Denning, DW; Cornely, OA; Chakrabarti, A
Bridging the knowledge gap on mycoses in Africa: Setting up a Pan-African Mycology Working Group.
MYCOSES. 2020; 63(3): 244-249.
Doi: 10.1111/myc.13044
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Jenks, JD; Spiess, B; Buchheidt, D; Hoenigl, M
(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples.
CURR FUNGAL INFECT R. 2019; 13(3): 129-136.
Doi: 10.1007/s12281-019-00342-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Prattes, J; Flick, H
Chronic infections of the lungs. Focal point: chronic Aspergillus and Pseudomonas infections
PNEUMOLOGE. 2019; 16(1): 47-64.
Doi: 10.1007/s10405-018-0224-4
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
Hoenigl, M; Gangneux, JP; Segal, E; Alanio, A; Chakrabarti, A; Chen, SC; Govender, N; Hagen, F; Klimko, N; Meis, JF; Pasqualotto, AC; Seidel, D; Walsh, TJ; Lagrou, K; Lass-Flörl, C; Cornely, OA; European Confederation of Medical Mycology (ECMM)
Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.
Mycoses. 2018; 61(11):885-894
Doi: 10.1111/myc.12836
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoenigl, M; Prattes, J; Neumeister, P; Wölfler, A; Krause, R
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Mycoses. 2018; 61(3):201-205
Doi: 10.1111/myc.12727
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway.
Surg Infect (Larchmt). 2017; 18(8):846-853
Doi: 10.1089/sur.2017.219
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hoenigl, M; Zollner-Schwetz, I; Sill, H; Linkesch, W; Lass-Flörl, C; Schnedl, WJ; Krause, R
Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
Mycoses. 2011; 54(5):454-459
Doi: 10.1111/j.1439-0507.2010.01881.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Traunmüller, F; Popovic, M; Konz, KH; Smolle-Jüttner, FM; Joukhadar, C
Efficacy and safety of current drug therapies for invasive aspergillosis.
Pharmacology. 2011; 88(3-4): 213-224.
Doi: 10.1159/000331860
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Langner, S; Staber, PB; Neumeister, P
Posaconazole in the management of refractory invasive fungal infections.
Ther Clin Risk Manag. 2008; 4(4): 747-758.
Doi: 10.2147/TCRM.S3329
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Domej, W; Hermann, J; Krause, R; Wehrschütz, M; Maier, A; Flögel, E
Lung cavities, mycetomas and hemoptysis
Wien Med Wochenschr. 2007; 157(19-20): 466-472.
Doi: 10.1007/s10354-007-0460-4
PubMed
FullText
FullText_MUG
Schmolzer, G; Urlesberger, B; Haim, M; Kutschera, J; Pichler, G; Ritschl, E; Resch, B; Reiterer, F; Müller, W
Multi-modal approach to prophylaxis of necrotizing enterocolitis: clinical report and review of literature.
PEDIAT SURG INT. 2006; 22(7): 573-580.
Doi: 10.1007/s00383-006-1709-5
Web of Science
PubMed
FullText
FullText_MUG
Degreef, H; del Palacio, A; Mygind, S; Ginter, G; Pinto Soares, A; Zuluaga de Cadena, A
Randomized double-blind comparison of short-term itraconazole and terbinafine therapy for toenail onychomycosis.
Acta Derm Venereol. 1999; 79(3):221-223
Doi: 10.1080%2F000155599750011020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ginter, G; Rieger, E; Heigl, K; Propst, E
Increasing frequency of onychomycoses--is there a change in the spectrum of infectious agents?
Mycoses. 1996; 39 Suppl 1:118-122
Doi: 10.1111/j.1439-0507.1996.tb00517.x
Web of Science
PubMed
FullText
FullText_MUG
Faschinger, C; Faulborn, J; Ganser, K
Infectious corneal ulcers--once with endophthalmitis--after photorefractive keratotomy with disposable contact lens
Klin Monbl Augenheilkd. 1995; 206(2):96-102
Doi: 10.1055/s-2008-1035411
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG